ERK1 as an important mediator of lysophosphatidic acid signaling leading to upregulation of sphingosine kinase 1 (SphK1) and point to SphK1 and sphingosine-1-phosphate production as potential therapeutic targets in gastric cancer [22]. The gene discussed is MAPK3; the disease is gastric cancer.